Authors:
Johnson, RE
Jones, HE
Jasinski, DR
Svikis, DS
Haug, NA
Jansson, LM
Kissin, WB
Alpan, G
Lantz, ME
Cone, EJ
Wilkins, DG
Golden, AS
Huggins, GR
Lester, BM
Citation: Re. Johnson et al., Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes, DRUG AL DEP, 63(1), 2001, pp. 97-103
Authors:
Lester, BM
ElSohly, M
Wright, LL
Smeriglio, VL
Verter, J
Bauer, CR
Shankaran, S
Bada, HS
Walls, HC
Huestis, MA
Finnegan, LP
Maza, PL
Citation: Bm. Lester et al., The maternal lifestyle study: Drug use by meconium toxicology and maternalself-report, PEDIATRICS, 107(2), 2001, pp. 309-317
Authors:
McGrath, MM
Sullivan, MC
Lester, BM
Oh, W
Citation: Mm. Mcgrath et al., Longitudinal neurologic follow-up in neonatal intensive care unit survivors with various neonatal morbidities, PEDIATRICS, 106(6), 2000, pp. 1397-1405
Citation: Ll. Lagasse et al., Interpreting research on prenatal substance exposure in the context of multiple confounding factors, CLIN PERIN, 26(1), 1999, pp. 39
Citation: Cfz. Boukydis et Bm. Lester, The NICU Network Neurobehavioral Scale - Clinical use with drug exposed infants and their mothers, CLIN PERIN, 26(1), 1999, pp. 213